Concepedia

Alan C.H. Lee

AC

Statistics

Publications

8

Citations

537

H-Index

8

Active since

2015

Affiliations

University of Hong Kong(Current)

Queen Mary Hospital

University College London

Aalborg University

Alan C.H. Lee is an author at University of Hong Kong specializing in diabetes, autoimmune disease, and renal disease.

ORCID

Top concepts

Publications per year

2015–2021

8

Publications

8

Association Between Dabigatran vs Warfarin and Risk of Osteoporotic Fractures Among Patients With Nonvalvular Atrial Fibrillation

Wallis C. Y. Lau, Esther W. Chan, Ching‐Lung Cheung et al. · JAMA · 2017 · 198 citations · Full text

Galectin-3 is independently associated with progression of nephropathy in type 2 diabetes mellitus

Kathryn Choon Beng Tan, Ching‐Lung Cheung, Alan C.H. Lee et al. · Diabetologia · 2018 · 80 citations · Full text

, , +11

Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation

Wallis C. Y. Lau, Ching‐Lung Cheung, Kenneth K. C. Man et al. · Annals of Internal Medicine · 2020 · 74 citations

Validity of major osteoporotic fracture diagnosis codes in the Clinical Data Analysis and Reporting System in Hong Kong

Chor‐Wing Sing, Yu Cho Woo, Alan C.H. Lee et al. · Pharmacoepidemiology and Drug Safety · 2017 · 73 citations

Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated with A Disintegrin And Metalloproteinase 10 in Type 1 Diabetes

Alan C.H. Lee, Joanne K.Y. Lam, Sammy W.M. Shiu et al. · PLoS ONE · 2015 · 36 citations · Full text

Rows per page

1–5 of 8